Benzinga | Mar 23, 2021 04:13PM EDT

aTyr Pharma Q4 EPS $(0.47) Beats $(0.82) Estimate, Sales $2.05M Beat $130.00K Estimate

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.82) by 42.68 percent. This is a 69.48 percent increase over losses of $(1.54) per share from the same period last year. The company reported quarterly sales of $2.05 million which beat the analyst consensus estimate of $130.00 thousand by 1.48K percent. This is a 1.32K percent increase over sales of $144.00 thousand the same period last year.